IE
IE · IE · IE-PA-EU/1/23/1730/001
Briumvi 150 mg Concentrate for solution for infusion
ATC L04AG14
Last synced from HPRA (Ireland) on
Identification
ManufacturerNeuraxpharm Pharmaceuticals S.L.
CountryIE (IE)
ATC codeL04AG14
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/23/1730/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L04",
"L04AG14"
],
"strength": null,
"pa_number": "EU/1/23/1730/001",
"substances": [
"Ublituximab"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "31/05/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L04AG14.
- ISBriumviNeuraxpharm Pharmaceuticals S.L.
- NOBriumviNeuraxpharm Pharmaceuticals, S.L.
- 🇨🇭Briumvi
- PLBriumviNeuraxpharm Pharmaceuticals, S.L.
- 🇨🇭BriumviNeuraxpharm Switzerland AG
- FIBriumviNeuraxpharm Pharmaceuticals S.L.
- DKBriumviNeuraxpharm Pharmaceuticals S.L.
- CZBRIUMVINeuraxpharm Pharmaceuticals, S.L., Barcelona
Access this data programmatically
Query Briumvi 150 mg Concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.